Mass General Brigham News

Massachusetts Eye and Ear and Massachusetts General Hospital (MGH) today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The AAVCOVID vaccine program was developed in the laboratory of Luk H. Vandenberghe, PhD, director of the Grousbeck Gene Therapy…

The Partners Innovation Fund (PIF) continues to add to their success in moving therapeutic strategies developed within the Partners HealthCare System (PHS) further down the development pipeline. Several recent deals and series A financing rounds support therapeutic strategies for cancer, fibrotic disease, rare endocrine and metabolic diseases and hypothyroidism, among others. Established in 2008, PIF’s…

Bayer and Partners HealthCare’s founding members Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to research new drug candidates to treat chronic lung diseases. The joint lab will host scientists from all three parties and Bayer is investing more than USD 30 million to fund…

If you’ve ever tried to take a picture of a squirming baby, you know how tough it can be to get a quality image of something that’s always on the move. A similar challenge can be found in the more advanced imaging tools used in healthcare diagnostics. To capture high-quality images using MRI or PET…

To view the honor and other women leaders in health care, click here.

Last week, Anne Klibanski, MD, CEO of Partners Healthcare, was named one of “The Top 25 Women in Healthcare” by Modern Healthcare. Dr. Klibanski, who has been my mentor since I started my endocrine fellowship in 1995, is clearly an exceptional scientist and a visionary leader. As she received this award, I asked myself, how…

Modern Health Care recently acknowledge the appointment of Anne Klibanski as named first female Partners HealthCare CEO and one of the magazine’s Top 25 Leaders in Healthcare for 2019. We celebrate this recognition and the work of innovative leaders across the healthcare spectrum. Celebrate Accomplishments Women Leaders in Healthcare

The Partners HealthCare Board of Directors has named Anne Klibanski, MD President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski becomes the first female chief executive of Partners HealthCare, the state’s largest private employer, with 75,000 employees. Dr. Klibanski was named Interim President and CEO in February. “Over the past several months, it has…

The first benchmarking study of health system efforts to generate new revenue streams evaluates a range of effective strategies to sustain overall operations, fuel innovation, and advance patient care missions. The report by Partners HealthCare and Fitzroy Health finds that successful health systems have increased operating margin as much as five points through diversification strategies.…

The Partners HealthCare Board of Directors has named Anne Klibanski, MD, Interim President and Chief Executive Officer of Partners HealthCare. Dr. Klibanski will succeed Dr. David Torchiana, who has served since March 2015 and will retire at the end of April. Earlier this month, Dr. Klibanski was recognized by Modern Healthcare as one of 2019’s…

Eureka! Sometimes that moment of personal discovery comes when you least expect it. Heather Berlin came to a revelation while she dangled 40 feet above the Sydney Zoo; Gregg Meyer, MD discovered how tears could make him a better doctor; and Yari Golden-Castaño’s dream of space flight might just take her to Mars. Three storytellers,…

Save the Date Westin Copley Place | Boston Wednesday, April 10, 2019 This invitation-only reception honors principal investigators and researchers who submitted invention disclosures during the calendar year 2018. The evening features a cocktail reception, live music from a PHS-member band, dinner and a keynote presentation by Alfred Sandrock, MD, PhD, Chief Medical Officer; EVP,…

Now that the Mass. Eye and Ear has officially joined Partners, leaders from both organizations are optimistic about the potential to drive new advances in treating blindness, deafness and other debilitating diseases of the head and neck. The move comes at a pivotal time as the promise of gene therapies for inherited eye and ear…